Package 0480-3685-01

{"route": ["ORAL"], "spl_id": "df4fa83e-494c-4091-8d34-9328fd030ccd", "openfda": {"unii": ["JJ768O327N", "O1ZPV620O4", "G83415V073", "6DPV8NK46S"], "rxcui": ["1927610", "1927617", "1927630", "1927637"], "spl_set_id": ["5e84ef60-3050-40d9-9f14-66b85d289e17"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0480-3685-01)", "package_ndc": "0480-3685-01", "marketing_start_date": "20231010"}], "brand_name": "dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate", "product_id": "0480-3685_df4fa83e-494c-4091-8d34-9328fd030ccd", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0480-3685", "dea_schedule": "CII", "generic_name": "dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate", "active_ingredients": [{"name": "AMPHETAMINE ASPARTATE MONOHYDRATE", "strength": "9.375 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "9.375 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "9.375 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "9.375 mg/1"}], "application_number": "ANDA210876", "marketing_category": "ANDA", "marketing_start_date": "20231010", "listing_expiration_date": "20261231"}